食品科学 ›› 2021, Vol. 42 ›› Issue (23): 34-41.doi: 10.7506/spkx1002-6630-20201015-130

• 基础研究 • 上一篇    下一篇

乳源抗菌肽BCp12对金黄色葡萄球菌多靶点抑菌机制

李钰芳,杨昆,顾韦维,赵琼,黄艾祥,施娅楠   

  1. (云南农业大学食品科学技术学院,云南?昆明 650201)
  • 出版日期:2021-12-15 发布日期:2021-12-29
  • 基金资助:
    国家自然科学基金地区科学基金项目(32060572);云南省农林专项重点项目(2018FG001-011); 云岭产业技术领军人才项目(云发改人事(2014)1782号)

Multi-target Antibacterial Mechanism of Milk-derived Antimicrobial Peptide BCp12 against Staphylococcus aureus

LI Yufang, YANG Kun, GU Weiwei, ZHAO Qiong, HUANG Aixiang, SHI Yanan   

  1. (College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China)
  • Online:2021-12-15 Published:2021-12-29

摘要: 为研究新型酪蛋白源抗菌肽BCp12对金黄色葡萄球菌的抑菌机理,本实验通过酶标仪、流式细胞仪、透射电子显微镜分析BCp12对金黄色葡萄球菌的壁膜损伤机制;采用荧光光谱、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳研究BCp12对菌体DNA结合及蛋白质合成的影响;利用赖氨酸乙酰化、琥珀酰化、2-羟基异丁酰化、丙二酰化4 种泛抗体结合免疫印迹分析BCp12对菌体蛋白翻译后修饰的影响。结果表明:BCp12的最小抑菌质量浓度(minimum inhibitory concentration,MIC)为2 mg/mL,经质量浓度超过MIC的BCp12处理后的菌体细胞膜疏水性显著下降(P≤0.001),通透性增加,菌体形变严重,部分细胞内容物外泄形成空腔;BCp12与溴化乙锭竞争性结合菌体DNA,使核酸合成受到抑制,胞内蛋白质量浓度显著下降(P≤0.001),特别是分子质量为15~35 kDa的蛋白变化最为明显,说明BCp12可抑制菌体蛋白质的合成;金黄色葡萄球菌蛋白存在大量的赖氨酸乙酰化、琥珀酰化、丙二酰化修饰,经BCp12处理的菌体赖氨酸丙二酰化修饰水平明显下调,而对赖氨酸琥珀酰化和2-羟基异丁酰化修饰的影响不明显。本实验揭示了BCp12对金黄色葡萄球菌的多靶点抑菌机制,对新型乳源抗菌肽的应用和保障食品安全具有一定的意义。

关键词: 抗菌肽BCp12;金黄色葡萄球菌;壁膜损伤;蛋白合成;丙二酰化修饰

Abstract: In this research, to investigate the antibacterial mechanism of a novel casein-derived antibacterial peptide, BCp12, against Staphylococcus aureus, the mechanism of cell membrane and wall damage caused by BCp12 was analyzed using a microplate reader (MR), a flow cytometer (FC), and a transmission electron microscope (TEM). The effects of BCp12 on DNA binding and protein synthesis were studied using fluorescence spectroscopy and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The influence of BCp12 on protein post-translational modification (PTM) was analyzed by Western blot using pan anti-acetyl, anti-succinyl, anti-2-hydroxyisobutyryl and anti-malonyl lysine antibodies. The results showed that the minimum inhibitory concentration (MIC) of BCp12 was 2 mg/mL. Treatment with BCp12 at concentrations above the MIC decreased the cell surface hydrophobicity of S. aureus significantly (P ≤ 0.001), increased the cell membrane permeability, and caused the cells to deform severely and cellular contents leak out to form a cavity. BCp12 competed with ethidium bromide to combine with bacterial DNA, resulting in inhibition of nucleic acid synthesis and significantly decreased protein contents (P ≤ 0.001), especially for proteins with a molecular mass of 15–35 kDa, indicating that BCp12 can inhibit the synthesis of bacterial proteins. S. aureus proteins showed a large number of lysine acetylation, succinylation and malonylation. The level of malonylation was significantly down-regulated after treatment with BCp12, which, however, had no noticeable effect on the level of 2-hydroxyisobutyrylation or succinylation. The results of this study are meaningful for applying new milk-derived antimicrobial peptides and ensuring food safety.

Key words: antimicrobial peptide BCp12; Staphylococcus aureus; wall and membrane damage; protein synthesis; malonylation

中图分类号: